Cell line · CVCL_1275
Papers31
1 to 20 of 31
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 Medulloblastoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Meningeal-tumor interactions define distinct modes of leptomeningeal colonization in Group 3 medulloblastoma. | Acta Neuropathol Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune Response. | Clin Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Single-cell multi-omics analysis identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma | Res Sq | 2024 | Its Methods give the RRID and name the line | PubMed | |
| The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas. | Int J Mol Sci | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells. | J Neurooncol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. | Mol Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells. | J Neurooncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Dynamic profiling of medulloblastoma surfaceome. | Acta Neuropathol Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. | Mol Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma. | Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. | bioRxiv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma. | Oncol Rep | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation. | Cell Death Differ | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma. | Cell Rep | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis. | J Clin Med | 2019 | Its Methods give the RRID and name the line | PubMed | |
| Data on the number and frequency of scientific literature citations for established medulloblastoma cell lines. | Data Brief | 2016 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1275/papers